Related Experiment Video
Updated: Apr 6, 2026

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
Published on: June 10, 2022
Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity
Satoshi Uchida1, Kazunori Kataoka2,3,4, Keiji Itaka5
1Laboratory of Clinical Biotechnology, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. suchida@bmw.t.u-tokyo.ac.jp.
Abstract:
Chemical modification of nucleosides in mRNA is an important technology to regulate the immunogenicity of mRNA. In this study, various previously reported mRNA formulations were evaluated by analyzing in vitro protein expression and immunogenicity in multiple cell lines. For the macrophage-derived cell line, RAW 264.7, modified mRNA tended to have reduced immunogenicity and increased protein expression compared to the unmodified mRNA. In contrast, in some cell types, such as hepatocellular carcinoma cells (HuH-7) and mouse embryonic fibroblasts (MEFs), protein expression was decreased by mRNA modification. Further analyses revealed that mRNA modifications decreased translation efficiency but increased nuclease stability. Thus, mRNA modification is likely to exert both positive and negative effects on the efficiency of protein expression in transfected cells and optimal mRNA formulation should be determined based on target cell types and transfection purposes.
Insights
Messenger RNA (mRNA) modification impacts protein expression and immunogenicity. Optimal mRNA formulation depends on cell type and transfection goals, balancing modified mRNA
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Chemical modification of nucleosides in mRNA is crucial for regulating its immunogenicity.
- Understanding the effects of modified mRNA on protein expression and immune response is vital for therapeutic applications.
Purpose of the Study:
- To evaluate various mRNA formulations for in vitro protein expression and immunogenicity across different cell lines.
- To determine the impact of mRNA modification on translation efficiency and nuclease stability.
Main Methods:
- In vitro analysis of protein expression in multiple cell lines, including RAW 264.7, HuH-7, and MEFs.
- Assessment of mRNA immunogenicity in macrophage-derived cell lines.
- Evaluation of translation efficiency and nuclease stability of modified mRNA.
Main Results:
- Modified mRNA showed reduced immunogenicity and increased protein expression in RAW 264.7 cells.
- Protein expression decreased in HuH-7 and MEF cells upon mRNA modification.
- mRNA modifications enhanced nuclease stability but reduced translation efficiency.
Conclusions:
- mRNA modification has dual effects on protein expression efficiency, varying by cell type.
- The choice of mRNA formulation should be tailored to specific cell targets and transfection objectives.
- Balancing immunogenicity, protein expression, and stability is key for effective mRNA-based therapies.
Related Concept Videos
Regulation of Expression at Multiple Steps
What is Gene Expression?
RNA Editing
Leaky Scanning
Nuclear Export of mRNA

